Neogen® Establishes Relationship with Biomatter

About this update from Neogen Corporation

LANSING, Mich. --(BUSINESS WIRE)-- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has entered into an arrangement with Biomatter, a leading enzyme design company, to leverage Biomatter’s proprietary Intelligent Architecture™ platform and Neogen’s expertise in the field of analytical development and technology to create new enzyme-based products. Biomatter’s Intelligent Architecture™ platform, based on AI and Physical modelling, enables the design of enzymes with unique capabilities, dramatically expanding how they can be used in food safety related applications. “This relationship marks a significant step forward in advancing food security,” said Dr. Jason Lilly , Neogen’s Chief Scientific Officer. “By combining our leadership and innovation in food testing and risk mitigation with Biomatter’s cutting-edge enzyme engineering capabilities, we’re unlocking new possibilities that can enhance detection, improve efficiency, and ultimately protect and enhance the quality and safety of the global food supply.” “It is a privilege to partner with Neogen to create new enzymes that will push the boundaries of food and animal safety solutions,” said Laurynas Karpus , Biomatter’s Chief Executive Officer. “Together, our teams aim to set new standards in the industry, making every step of the process more efficient, cost-effective, and ultimately more beneficial for the end user.” About Neogen Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers. About Biomatter Biomatter is a next-generation enzyme design company breaking the limits of traditional protein engineering. Leveraging its generative AI-powered Intelligent Architecture™ platform, the company designs novel, high-performance enzymes from the ground up. Through collaborations with industry leaders in medicine, diagnostics, agriculture, and biomanufacturing, Biomatter delivers unique enzymatic solutions that enable differentiated products and promote a healthier, more sustainable world. Discover more at www.biomatter.ai . View source version on businesswire.com : https://www.businesswire.com/news/home/20250811673273/en/ [email protected] [email protected] Source: Neogen® Corporation

View stock analysis, news, and events for Neogen Corporation